Arvinas and Pfizer have been working to develop vepdegestrant, an estrogen receptor protein degrader under review by the Food and Drug Administration as a breast cancer treatment. The companies said ...

Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrantAdditional cost optimization ...

Saving reproductive tissue from kids treated for cancer before adolescence could give them a chance at having biological children later in life.

Research indicates that men and women experience pain differently due to biological, hormonal, and neurological variations.

“Starting hormone replacement therapy early may give the brain some protection, but if a woman already has Alzheimer’s or ...

Monte Rosa Therapeutics stock surged after expanding its Novartis partnership. Click here to learn about their innovative ...

ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...

Monte Rosa will receive a total transaction value of $5.7 billion. According to the terms of the agreement, in this collaboration, Novartis obtained ...

Q: We’re planning to get pregnant, and I wondered what you could suggest to make sure I have a healthy baby? — Donna R., Fort Worth, Texas ...

A team from Sun Yat-sen University Sun Yat-sen Memorial Hospital has identified a novel mechanism underlying platinum resistance in triple-negative breast cancer (TNBC): the circular RNA circSCAP ...

The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.

Nutritionist Lovneet Batra recently shared that bone density suffers, and calcium is transferred to the foetus during ...